Drug Testing Locations - Fort Greely, AK

Drug Testing in Fort Greely, AK

Fort Greely, Alaska Statistics

In Fort Greely, located in Southeast Fairbanks Census Area, drug-related arrests increased by 15% in the last reported year.

Southeast Fairbanks Census Area, which includes Fort Greely, reported a 12% rise in substance abuse cases over the past year.

Fort Greely's Southeast Fairbanks Census Area saw a 20% higher hospital admission rate for drug overdoses compared to the state average.

A recent survey indicated that 18% of young adults in Fort Greely have experimented with illicit drugs.

Drug treatment enrollments in Southeast Fairbanks Census Area increased by 10% from the previous year.

Fort Greely reported a 7% decline in drug-related school suspensions last year.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Fort Greely, AK & Drug Testing Policies

Employers in Fort Greely, AK, enforce strict drug testing policies to maintain a safe and productive work environment. The U.S. Department of Labor outlines guidelines that many local employers follow, including mandatory pre-employment drug tests and random testing protocols.

Additionally, businesses aligned with federal regulations, such as those in the defense sector, stringently adhere to Department of Defense mandates on drug-free workplace policies. This ensures a focus on safety, particularly in industries crucial to national security.

Government Efforts with Drug Problems in Fort Greely, AK

In Fort Greely, AK, efforts to address drug abuse are robust and ongoing. The Alaska Department of Health and Social Services supports programs aimed at reducing substance abuse through prevention and education initiatives. Local law enforcement collaborates with state and federal agencies to tackle drug distribution.

Moreover, the Substance Abuse and Mental Health Services Administration (SAMHSA) provides resources and funding to enhance community programs focused on rehabilitation and recovery. These partnerships strive to mitigate the impact of drug abuse in Southeast Fairbanks Census Area, covering Fort Greely and neighboring regions.

Local Drug Busts & News in Fort Greely, AK

Fort Greely has been the site of several notable drug busts in recent years, highlighting ongoing concerns in the area. Local law enforcement, in coordination with state agencies, frequently conducts operations to dismantle drug trafficking operations in Southeast Fairbanks Census Area.

Recent efforts have included the interception of cross-border drug smuggling attempts, reflecting the area's strategic geographical challenges. These initiatives underscore the commitment to curtailing the presence and impact of illegal substances in the community, strengthening safety for all residents.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Fort Greely, AK. Trusted by employers nationwide for accurate results and exceptional service.

Alaska DOT/Non DOT Physicals

Alaska Vision Tests

Alaska Audiograms

Alaska Respirator Fit Tests

Alaska Lift Tests

Alaska Background Checks

Clinical Testing Services

TB Testing in AK

Diabetes Testing in AK

Infectious Disease Testing in AK

Sickle Cell Anemia Testing in AK

Women/Men's Health Testing in AK

Resources & Citations

Recovery.org

Yukon Wellness

Alaska Native Network

Alcoholics Anonymous

Drug Rehab

Narconon

Addiction Center

American Addiction Centers

SAMHSA

Crisis Response

Drug Testing Near Fort Greely, AK

Dot Lake Village, AK

Dot Lake, AK

Harding-Birch Lakes, AK

Healy Lake, AK

Donnelly, AK

Deltana, AK

Delta Junction, AK

Big Delta, AK

Frequently Asked Questions

Customer Reviews